Open access
Open access
Powered by Google Translator Translator

RIP Hydroxychloroquine? 2 studies show no benefit in early/mild COVID-19

17 Jul, 2020 | 08:59h | UTC

Study 1: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial – Annals of Internal Medicine

Study 2: Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial – Clinical Infectious Diseases

Commentaries: New Covid-19 study, despite flaws, adds to case against hydroxychloroquine – STAT AND Hydroxychloroquine also doesn’t help Covid-19 patients who aren’t hospitalized, new study finds – CNN

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.